Anlon Healthcare (NSE:AHCL) ROE % Adjusted to Book Value: 7.10% (As of Mar. 2026)


NSE:AHCL Anlon Healthcare Ltd NSE:AHCL
17 GF Score
Price ₹15.90
! 5 Warning Signs
View Full Analysis

What is Anlon Healthcare ROE % Adjusted to Book Value?

Anlon Healthcare NSE:AHCL 17 ROE % Adjusted to Book Value is 7.10% as of Mar. 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 17/100. The stock has 5 warning signs investors should review.

Anlon Healthcare's ROE % for the quarter that ended in Mar. 2026 was 18.24%. Anlon Healthcare's PB Ratio for the quarter that ended in Mar. 2026 was 2.57. Anlon Healthcare's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 7.10%.

Anlon Healthcare ROE % Adjusted to Book Value Related Terms

Anlon Healthcare ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Anlon Healthcare's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anlon Healthcare ROE % Adjusted to Book Value Chart

Anlon Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00 7.14

Anlon Healthcare Quarterly Data
Mar22 Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 7.78 0.00 7.10

NSE:AHCL vs ZTS, UTHR: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Anlon Healthcare's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anlon Healthcare ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anlon Healthcare's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Anlon Healthcare's ROE % Adjusted to Book Value falls into.


NSE:AHCL
17GF Score
Anlon Healthcare Ltd NSE:AHCL
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anlon Healthcare ROE % Adjusted to Book Value Calculation

Anlon Healthcare's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=18.36% / 2.57
=7.14%

Anlon Healthcare's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=18.24% / 2.57
=7.10%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 7.10% mean?
Anlon Healthcare (NSE:AHCL) has a ROE % Adjusted to Book Value of 7.10% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Anlon Healthcare and its competitors.
Is Anlon Healthcare's ROE % Adjusted to Book Value too high?
Anlon Healthcare's current ROE % Adjusted to Book Value is 7.10%. Overall, Anlon Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's ROE % Adjusted to Book Value compare to ZTS and UTHR?
Anlon Healthcare's ROE % Adjusted to Book Value of 7.10% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Anlon Healthcare and its competitors. Anlon Healthcare's current ROE % Adjusted to Book Value is 7.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current ROE % Adjusted to Book Value of 7.10%. The current ROE % Adjusted to Book Value is 7.10%. Anlon Healthcare's overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current ROE % Adjusted to Book Value is 7.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anlon Healthcare Business Description

Other Exchanges 544497:India
Address Kalawad Road, 101/102, Silvercoin Complex, Opposite Crystal Mall, Rajkot, GJ, IND, 360 005
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
17GF Score

Get the complete analysis for NSE:AHCL

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.90
Price